These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 17018162
1. Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania. Holzmuller P, Bras-Gonçalves R, Lemesre JL. Parasitology; 2006; 132 Suppl():S19-32. PubMed ID: 17018162 [Abstract] [Full Text] [Related]
2. Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities. Holzmuller P, Hide M, Sereno D, Lemesre JL. Infect Genet Evol; 2006 May; 6(3):187-97. PubMed ID: 15905133 [Abstract] [Full Text] [Related]
3. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis. Holzmuller P, Cavaleyra M, Moreaux J, Kovacic R, Vincendeau P, Papierok G, Lemesre JL. Vet Immunol Immunopathol; 2005 Jul 15; 106(3-4):247-57. PubMed ID: 15963823 [Abstract] [Full Text] [Related]
4. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339 [Abstract] [Full Text] [Related]
5. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro. Hockmeyer WT, Walters D, Gore RW, Williams JS, Fortier AH, Nacy CA. J Immunol; 1984 Jun 22; 132(6):3120-5. PubMed ID: 6725948 [Abstract] [Full Text] [Related]
6. [Nitric oxide and anti-protozoan chemotherapy]. Gradoni L, Ascenzi P. Parassitologia; 2004 Jun 22; 46(1-2):101-3. PubMed ID: 15305696 [Abstract] [Full Text] [Related]
7. Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms. Lemesre JL, Sereno D, Daulouède S, Veyret B, Brajon N, Vincendeau P. Exp Parasitol; 1997 May 22; 86(1):58-68. PubMed ID: 9149241 [Abstract] [Full Text] [Related]
8. [Leishmaniasis: principles of the immune response and function of nitric oxide]. Bogdan C. Berl Munch Tierarztl Wochenschr; 1998 May 22; 111(11-12):409-14. PubMed ID: 9880934 [Abstract] [Full Text] [Related]
9. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate. Vouldoukis I, Rougier S, Dugas B, Pino P, Mazier D, Woehrlé F. Vet Parasitol; 2006 Jan 30; 135(2):137-46. PubMed ID: 16242844 [Abstract] [Full Text] [Related]
10. Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products. Mauël J, Ransijn A. Exp Parasitol; 1997 Oct 30; 87(2):98-111. PubMed ID: 9326885 [Abstract] [Full Text] [Related]
11. Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Rochette A, Raymond F, Corbeil J, Ouellette M, Papadopoulou B. Mol Biochem Parasitol; 2009 May 30; 165(1):32-47. PubMed ID: 19393160 [Abstract] [Full Text] [Related]
12. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes. Nacy CA, Meltzer MS, Fortier AH. J Immunol; 1984 Dec 30; 133(6):3344-50. PubMed ID: 6491291 [Abstract] [Full Text] [Related]
13. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation. Kram D, Thäle C, Kolodziej H, Kiderlen AF. J Immunol Methods; 2008 Apr 20; 333(1-2):79-88. PubMed ID: 18313691 [Abstract] [Full Text] [Related]
14. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic. Panosian CB, Sypek JP, Wyler DJ. J Immunol; 1984 Dec 20; 133(6):3358-65. PubMed ID: 6208278 [Abstract] [Full Text] [Related]
15. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, Vincendeau P, Lemesre JL. Infect Immun; 2002 Jul 20; 70(7):3727-35. PubMed ID: 12065515 [Abstract] [Full Text] [Related]
16. Leishmania major-mediated prevention of programmed cell death induction in infected macrophages is associated with the repression of mitochondrial release of cytochrome c. Akarid K, Arnoult D, Micic-Polianski J, Sif J, Estaquier J, Ameisen JC. J Leukoc Biol; 2004 Jul 20; 76(1):95-103. PubMed ID: 15075349 [Abstract] [Full Text] [Related]
17. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. Evans TG, Thai L, Granger DL, Hibbs JB. J Immunol; 1993 Jul 15; 151(2):907-15. PubMed ID: 8335918 [Abstract] [Full Text] [Related]
18. Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function. Osorio y Fortéa J, Prina E, de La Llave E, Lecoeur H, Lang T, Milon G. Immunol Rev; 2007 Oct 15; 219():66-74. PubMed ID: 17850482 [Abstract] [Full Text] [Related]
19. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages. Nacy CA, Meltzer MS, Leonard EJ, Wyler DJ. J Immunol; 1981 Dec 15; 127(6):2381-6. PubMed ID: 7299130 [Abstract] [Full Text] [Related]
20. Characterization of the anti-Leishmania effect induced by cisplatin, an anticancer drug. Tavares J, Ouaissi M, Ouaissi A, Cordeiro-da-Silva A. Acta Trop; 2007 Aug 15; 103(2):133-41. PubMed ID: 17658446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]